当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to Lancet Oncol 2020; 21: 508-18.
The Lancet Oncology ( IF 51.1 ) Pub Date : 2020-04-01 , DOI: 10.1016/s1470-2045(20)30177-7


Pishvaian MJ, Blais EM, Brody JR, et al. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. Lancet Oncol 2020; 21: 508–18.—In this Article, the x-axis label of figure 3B should have been “Time on therapy without disease progression (months)”. This correction has been made to the online version as of March 30, 2020, and the printed Article is correct.

中文翻译:

柳叶刀Oncol 2020的更正; 21:508-18。

Pishvaian MJ,Blais EM,Brody JR等。在分子谱分析后接受匹配治疗的胰腺癌患者的总生存期:“了解您的肿瘤”注册研究的回顾性分析。《柳叶刀》《 Oncol 2020》; 21:508-18。-在本文中,图3B的x轴标签应为“无疾病进展的治疗时间(月)”。截至2020年3月30日,在线版本已进行了更正,并且印刷的文章正确无误。
更新日期:2020-03-31
down
wechat
bug